Search

Susan T Tran

Examiner (ID: 251, Phone: (571)272-0606 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1618, 1615
Total Applications
1909
Issued Applications
1053
Pending Applications
242
Abandoned Applications
650

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20391738 [patent_doc_number] => 20250367213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-04 [patent_title] => IMMEDIATE RELEASE MULTILAYER TABLET [patent_app_type] => utility [patent_app_number] => 19/301647 [patent_app_country] => US [patent_app_date] => 2025-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9671 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19301647 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/301647
IMMEDIATE RELEASE MULTILAYER TABLET Aug 14, 2025 Pending
Array ( [id] => 20277727 [patent_doc_number] => 20250302969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-02 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE [patent_app_type] => utility [patent_app_number] => 19/238194 [patent_app_country] => US [patent_app_date] => 2025-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19238194 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/238194
PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE Jun 12, 2025 Pending
Array ( [id] => 20320020 [patent_doc_number] => 20250332108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-30 [patent_title] => COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL [patent_app_type] => utility [patent_app_number] => 19/221432 [patent_app_country] => US [patent_app_date] => 2025-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66725 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19221432 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/221432
COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL May 27, 2025 Pending
Array ( [id] => 20178263 [patent_doc_number] => 20250262221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => IMMEDIATE RELEASE MULTILAYER TABLET [patent_app_type] => utility [patent_app_number] => 19/190529 [patent_app_country] => US [patent_app_date] => 2025-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19190529 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/190529
IMMEDIATE RELEASE MULTILAYER TABLET Apr 24, 2025 Pending
Array ( [id] => 20185855 [patent_doc_number] => 12396955 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-26 [patent_title] => Tamper resistant dosage forms [patent_app_type] => utility [patent_app_number] => 19/174583 [patent_app_country] => US [patent_app_date] => 2025-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 43 [patent_no_of_words] => 57361 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19174583 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/174583
Tamper resistant dosage forms Apr 8, 2025 Issued
Array ( [id] => 20231199 [patent_doc_number] => 20250288518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-18 [patent_title] => METHODS OF USING RADIPRODIL IN THE TREATMENT OF DISORDERS [patent_app_type] => utility [patent_app_number] => 19/171169 [patent_app_country] => US [patent_app_date] => 2025-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41900 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19171169 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/171169
METHODS OF USING RADIPRODIL IN THE TREATMENT OF DISORDERS Apr 3, 2025 Pending
Array ( [id] => 19830795 [patent_doc_number] => 20250082581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => TAMPER RESISTANT DOSAGE FORMS [patent_app_type] => utility [patent_app_number] => 18/953603 [patent_app_country] => US [patent_app_date] => 2024-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18953603 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/953603
Tamper resistant dosage forms Nov 19, 2024 Issued
Array ( [id] => 19752861 [patent_doc_number] => 20250041426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE [patent_app_type] => utility [patent_app_number] => 18/921291 [patent_app_country] => US [patent_app_date] => 2024-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3804 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18921291 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/921291
Pharmaceutical compositions comprising bupropion and cysteine Oct 20, 2024 Issued
Array ( [id] => 19938870 [patent_doc_number] => 12310984 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-05-27 [patent_title] => Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals [patent_app_type] => utility [patent_app_number] => 18/830440 [patent_app_country] => US [patent_app_date] => 2024-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 0 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18830440 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/830440
Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals Sep 9, 2024 Issued
Array ( [id] => 19613135 [patent_doc_number] => 20240398815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => ADAGRASIB SOLID PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/794390 [patent_app_country] => US [patent_app_date] => 2024-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18794390 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/794390
Adagrasib solid pharmaceutical compositions Aug 4, 2024 Issued
Array ( [id] => 19570233 [patent_doc_number] => 20240374525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => ADAGRASIB SOLID PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/784276 [patent_app_country] => US [patent_app_date] => 2024-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10074 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18784276 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/784276
ADAGRASIB SOLID PHARMACEUTICAL COMPOSITIONS Jul 24, 2024 Pending
Array ( [id] => 19526503 [patent_doc_number] => 20240350405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => FAST DISINTEGRATING TABLET [patent_app_type] => utility [patent_app_number] => 18/760150 [patent_app_country] => US [patent_app_date] => 2024-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18760150 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/760150
FAST DISINTEGRATING TABLET Jun 30, 2024 Pending
Array ( [id] => 19430838 [patent_doc_number] => 20240299336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => SHELF-STABLE FORMULATIONS OF BENZOYL PEROXIDE AND METHODS OF PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 18/666141 [patent_app_country] => US [patent_app_date] => 2024-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25104 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18666141 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/666141
SHELF-STABLE FORMULATIONS OF BENZOYL PEROXIDE AND METHODS OF PRODUCING SAME May 15, 2024 Abandoned
Array ( [id] => 19768340 [patent_doc_number] => 20250049766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => HIGH DOSAGE TEBIPENEM PIVOXIL TABLET FORMULATION [patent_app_type] => utility [patent_app_number] => 18/665330 [patent_app_country] => US [patent_app_date] => 2024-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18410 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18665330 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/665330
HIGH DOSAGE TEBIPENEM PIVOXIL TABLET FORMULATION May 14, 2024 Pending
Array ( [id] => 19417323 [patent_doc_number] => 20240293446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => TCM THROAT TEA METHOD AND COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/661506 [patent_app_country] => US [patent_app_date] => 2024-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5367 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18661506 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/661506
TCM THROAT TEA METHOD AND COMPOSITION May 9, 2024 Abandoned
Array ( [id] => 19343467 [patent_doc_number] => 20240252430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => ALLERGENIC PROTEIN FORMULATIONS FOR IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 18/629431 [patent_app_country] => US [patent_app_date] => 2024-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6726 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18629431 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/629431
ALLERGENIC PROTEIN FORMULATIONS FOR IMMUNOTHERAPY Apr 7, 2024 Pending
Array ( [id] => 19593136 [patent_doc_number] => 12150954 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-11-26 [patent_title] => Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals [patent_app_type] => utility [patent_app_number] => 18/618702 [patent_app_country] => US [patent_app_date] => 2024-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4336 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18618702 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/618702
Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals Mar 26, 2024 Issued
Array ( [id] => 19447183 [patent_doc_number] => 20240307313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/609809 [patent_app_country] => US [patent_app_date] => 2024-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16746 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609809 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/609809
OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF Mar 18, 2024 Pending
Array ( [id] => 19960379 [patent_doc_number] => 12329851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-17 [patent_title] => Long acting injectable formulation comprising risperidone and biodegradable polymers [patent_app_type] => utility [patent_app_number] => 18/585349 [patent_app_country] => US [patent_app_date] => 2024-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 28057 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 396 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18585349 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/585349
Long acting injectable formulation comprising risperidone and biodegradable polymers Feb 22, 2024 Issued
Array ( [id] => 19730181 [patent_doc_number] => 12208167 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-01-28 [patent_title] => Coated tablets for pH-dependent release of benzgalantamine [patent_app_type] => utility [patent_app_number] => 18/434155 [patent_app_country] => US [patent_app_date] => 2024-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 24124 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18434155 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/434155
Coated tablets for pH-dependent release of benzgalantamine Feb 5, 2024 Issued
Menu